trending Market Intelligence /marketintelligence/en/news-insights/trending/fcavb-ddzp8de1hc5cn9hw2 content esgSubNav
In This List

Aralez Pharmaceuticals chief commercial officer resigns

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Aralez Pharmaceuticals chief commercial officer resigns

Mark Glickman has resigned as chief commercial officer of Aralez Pharmaceuticals Inc. to pursue other opportunities.

Glickman's resignation will be effective as of March 30.